PEOPLE - Bayer Healthcare makes appointment:
This article was originally published in Clinica
Executive Summary
Bayer Healthcare has appointed Dr Peter Knuppel as director of the diagnostics division of Bayer Vital (Fernwald, Giebetaen), its German distribution company. He replaces Dr Roberto Parotelli, who was appointed director of marketing and distribution for Europe and Japan of the self-testing systems division this summer. Since July 2000, Dr Knuppel has been the worldwide director of parent company Bayer's molecular testing diagnostics division.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.